Document is current
Any future updates will be listed below
-
Authors
Harbottle, Zoe
Nötzel, Amanda
Golding, Michael A.
Bhamra, Manvir
Kopsch, Isac
Wilking, Erik
Jonsson, Marina
Abrams, Elissa M.
Halbrich, Michelle A.
Simons, Elinor
Roos, Leslie E.
Keddy-Grant, Jill A.
Gerstner, Thomas V.
St-Vincent, Jo-Anne
Ekström, Sandra
Protudjer, Jennifer L. P. http://orcid.org/0000-0002-3888-8688
-
Funding
Funding for this research was provided by:
Research Manitoba (Research Manitoba)
- License Information
-
More Information
Article History
Received: 16 October 2023
Accepted: 28 February 2024
First Online: 22 March 2024
Declarations
:
: This study was approved by the University of Manitoba Health Research Ethics Board HS24294 (H2020:426).
: All authors have read and approved the submitted version of the manuscript.
: ZH declares no real or perceived conflicts of interest. AN declares no real or perceived conflicts of interest. MG declares no real or perceived conflicts of interest. MB declares no real or perceived conflicts of interest. IK declares no real or perceived conflicts of interest. EW declares no real or perceived conflicts of interest. MJ declares no real or perceived conflicts of interest. EA declares no real or perceived conflicts of interest. MH declares no real or perceived conflicts of interest. ES declares no real or perceived conflicts of interest. LR declares no real or perceived conflicts of interest. JK-G declares no real or perceived conflicts of interest. TG declares no real or perceived conflicts of interest. JS-V declares no real or perceived conflicts of interest. SE declares no real or perceived conflicts of interest. JP is Section Head, Allied Health, and Co-Lead, Research Pillar, Canadian Society of Allergy and Clinical Immunology; and is on the steering committee for Canada’s National Food Allergy Action Plan. She reports consulting for Ajinomoto Cambrooke, Novartis, Nutricia and ALK Abelló.
